HUMAN INTERLEUKIN-4

被引:0
|
作者
BANCHEREAU, J
DEFRANCE, T
GALIZZI, JP
MIOSSEC, P
ROUSSET, F
机构
关键词
INTERLEUKIN-4; LYMPHOCYTES; CYTOKINE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human IL-4 is a mature 129 AA glycoprotein, mostly secreted by activated T cells. It is a pleiotropic cytokine which acts on T and B lymphocytes, monocytes, polymorphonuclear cells, fibroblasts and endothelial cells. In addition it acts at various stages of cell differentiation and its effects are also dependent on the cytokine environment. In particular, IL-4 blocks some of the effects of IL-2 whereas interferon gamma blocks some of the effects of IL-4. In vitro and in vivo experiments in mouse and in vitro experiments in man have shown that IL-4 plays a crucial role in the induction of IgE production, whereas interferons counteract this effect. Human IL-4 binds to a high affinity receptor which is composed at least of one 130-kDa glycoprotein of 800 AA, a member of the newly described hematopoietin receptor superfamily. IL-4 may prove useful as an antitumoral and antiinflammatory agent.
引用
收藏
页码:299 / 306
页数:8
相关论文
共 50 条
  • [41] Interleukin-3 and interleukin-4 in childhood brucellosis
    Galanakis, E
    Makis, A
    Bourantas, KL
    Papadopoulou, ZL
    INFECTION, 2002, 30 (01) : 33 - 34
  • [42] Interleukin-7 activates human naive CD4(+) cells and primes for interleukin-4 production
    Webb, LMC
    Foxwell, BM
    Feldmann, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (03) : 633 - 640
  • [43] Effects of phosphodiesterase inhibitors on interleukin-4 and interleukin-13 generation from human basophils
    Eskandari, N
    Wickramasinghe, T
    Peachell, PT
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (08) : 1265 - 1272
  • [44] A novel polymorphism in the 5′ promoter region of the human interleukin-4 receptor α-chain gene is associated with decreased soluble interleukin-4 receptor protein levels
    Hackstein, H
    Hecker, M
    Kruse, S
    Bohnert, A
    Ober, C
    Deichmann, KA
    Bein, G
    IMMUNOGENETICS, 2001, 53 (04) : 264 - 269
  • [46] Interleukin-4 in patients with prostate cancer
    Ueda, T
    Sadar, MD
    Suzuki, H
    Akakura, K
    Sakamoto, S
    Shimbo, M
    Suyama, T
    Imamoto, T
    Komiya, A
    Yukio, N
    Ichikawa, T
    ANTICANCER RESEARCH, 2005, 25 (6C) : 4595 - 4598
  • [47] A monoclonal antibody to equine interleukin-4
    Wagner, B
    Hillegas, JM
    Antczak, DF
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2006, 110 (3-4) : 363 - 367
  • [48] The role of interleukin-4 in rheumatic diseases
    Dong, Chen
    Fu, Ting
    Ji, Juan
    Li, Zhenyu
    Gu, Zhifeng
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2018, 45 (08) : 747 - 754
  • [49] An update on interleukin-4 and its receptor
    Chomarat, P
    Banchereau, J
    EUROPEAN CYTOKINE NETWORK, 1997, 8 (04) : 333 - 344
  • [50] Interleukin-4 and Interleukin-13 Gene Polymorphisms in Children With Idiopathic Nephrotic Syndrome
    Al Rushood, Maysoun
    Al-Eisa, Amal A.
    Haider, Mohammad Z.
    FRONTIERS IN PEDIATRICS, 2020, 8